However, a case of rapid progression (acute transformation) of adult T-cell leukemia/lymphoma (ATL) was reported following anti-programmed cell death 1 (PD-1) antibody treatment for HTLV-1 carriers with low-grade ATL (chronic type) [9]. Here, PDCD1 is linked to adult T-cell leukemia/lymphoma.